• Sign up
  • Login

Scheme Profile

Mirae Asset Healthcare Fund - Regular (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
3,442
Inception Date
02-07-2018
Category
Equity - Sectoral

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 46.447 (31-Aug-2026) / 36.013 (29-Jan-2026)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 45.71 ( -0.31) ( -0.68 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Vrijesh Kasera
  • Value of () 1,00,000 since inception
  • 4,57,080
  • Entry Load
  • Nil
  • Exit Load
  • IF REDEEMED WITHIN 1 MONTH (30 DAYS) FROM THE DATE OF ALLOTMENT: 1% IF REDEEMED AFTER 1 MONTH (30 DAYS) FROM THE DATE OF ALLOTMENT: Nil
  • Expense Ratio (%)
  • 2.04
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 60.95 times
  • Portfolio P/B
  • 9.23 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.30

Risk Factors

  • Jenson's Alpha
  • 15.30
  • Standard Deviation
  • 4.65
  • Beta
  • 0.67
  • Sharpe
  • 1.01
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.13

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Jul 2026 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 19,12,104
  • 11.06
  • Divis Laboratories Ltd
  • Equity
  • 3,72,182
  • 8.71
  • Torrent Pharmaceuticals Ltd
  • Equity
  • 5,02,204
  • 7.47
  • Apollo Hospitals Enterprise Ltd
  • Equity
  • 2,28,296
  • 5.94
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 8,51,705
  • 5.53

Sector Top 5 Holdings

  [ As on 31 Jul 2026 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,34,61,945
  • 75.73
  • Healthcare
  • 59,14,080
  • 23.21
  • Chemicals
  • 1,94,500
  • 1.06

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 19.98 1.86 - -10.18 3,442.28
2025 -3.79 6.46 - 8.55 2,770.84
2024 38.73 18.51 10.35 8.12 2,863.52
2023 34.45 25.15 38.35 18.10 2,035.25
2022 -11.94 1.23 -11.31 2.80 1,631.86
2021 25.76 23.27 20.57 21.69 1,935.10
2020 73.37 27.28 62.19 15.60 1,209.93
2019 6.24 7.39 -3.06 13.79 366.91
2018 2.65 2.53 -5.45 6.67 314.94

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Jun-2026 16.02 10.73 - 0 3,252.54
Mar-2026 -0.73 -14.34 - 0 2,753.72
Dec-2025 0.42 5.97 - 0 2,770.84
Sep-2025 -1.04 -4.00 - 0 2,761.64

Peer Comparison

<< < 12345> >> 

Asset Allocation

Sector Allocation

Quick links

Close